Semple DJ - Search Results

1

Mortality After Home Hemodialysis Treatment Failure and Return to In-Center Hemodialysis.

Semple DJ, Sypek M, Ullah S, Davies C, McDonald S. Semple DJ, et al. Am J Kidney Dis. 2022 Jan;79(1):15-23.e1. doi: 10.1053/j.ajkd.2021.05.021. Epub 2021 Jul 16. Am J Kidney Dis. 2022. PMID: 34274359

2

Prognostic value and long-term variation of high sensitivity troponin T in clinically stable haemodialysis patients.

Honneger Bloch S, Semple D, Sidhu K, Stewart R, Pilmore H. Honneger Bloch S, et al. N Z Med J. 2014 Sep 12;127(1402):97-109. N Z Med J. 2014. PMID: 25228425

3

Changing ethnic and clinical trends and factors associated with successful home haemodialysis at Auckland District Health Board.

Beig JY, Semple DJ. Beig JY, et al. Among authors: semple dj. Intern Med J. 2019 Nov;49(11):1425-1435. doi: 10.1111/imj.14240. Intern Med J. 2019. PMID: 30719826

4

Effect of patient- and center-level characteristics on uptake of home dialysis in Australia and New Zealand: a multicenter registry analysis.

Ethier I, Cho Y, Hawley C, Pascoe EM, Roberts MA, Semple D, Nadeau-Fredette AC, Sypek MP, Viecelli A, Campbell S, van Eps C, Isbel NM, Johnson DW. Ethier I, et al. Nephrol Dial Transplant. 2020 Nov 1;35(11):1938-1949. doi: 10.1093/ndt/gfaa002. Nephrol Dial Transplant. 2020. PMID: 32031636

5

Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial.

Marshall MR, Vandal AC, de Zoysa JR, Gabriel RS, Haloob IA, Hood CJ, Irvine JH, Matheson PJ, McGregor DOR, Rabindranath KS, Schollum JBW, Semple DJ, Xie Z, Ma TM, Sisk R, Dunlop JL. Marshall MR, et al. Among authors: semple dj. J Am Soc Nephrol. 2020 May;31(5):1078-1091. doi: 10.1681/ASN.2019090877. Epub 2020 Mar 18. J Am Soc Nephrol. 2020. PMID: 32188697 Free PMC article. Clinical Trial.

6

Multicenter registry analysis comparing survival on home hemodialysis and kidney transplant recipients in Australia and New Zealand.

Ethier I, Cho Y, Hawley C, Pascoe EM, Roberts MA, Semple D, Nadeau-Fredette AC, Wong G, Lim WH, Sypek MP, Viecelli AK, Campbell S, van Eps C, Isbel NM, Johnson DW. Ethier I, et al. Nephrol Dial Transplant. 2021 Sep 27;36(10):1937-1946. doi: 10.1093/ndt/gfaa159. Nephrol Dial Transplant. 2021. PMID: 32879952

7

Variability and trends over time and across centres in haemodialysis weekly duration in Australia and New Zealand.

Ethier I, Cho Y, Davies CE, Hawley CM, Campbell SB, Isbel NM, Pascoe EM, Polkinghorne KR, Roberts M, See EJ, Semple D, van Eps C, Viecelli AK, Johnson DW. Ethier I, et al. Nephrology (Carlton). 2021 Feb;26(2):153-163. doi: 10.1111/nep.13782. Epub 2020 Oct 22. Nephrology (Carlton). 2021. PMID: 33094549

8

Dialysis initiation in older persons across centres and over time in Australia and New Zealand.

Ethier I, Campbell SB, Cho Y, Hawley CM, Isbel NM, Krishnasamy R, Roberts MA, Semple D, Sypek M, Viecelli AK, Johnson DW. Ethier I, et al. Nephrology (Carlton). 2021 Jul;26(7):613-622. doi: 10.1111/nep.13873. Epub 2021 Mar 18. Nephrology (Carlton). 2021. PMID: 33715269

9

Dialysis modality utilization patterns and mortality in older persons initiating dialysis in Australia and New Zealand.

Ethier I, Campbell SB, Cho Y, Hawley CM, Isbel NM, Krishnasamy R, Roberts MA, Semple D, Sypek M, Viecelli AK, Johnson DW. Ethier I, et al. Nephrology (Carlton). 2022 Aug;27(8):663-672. doi: 10.1111/nep.14073. Epub 2022 Jun 22. Nephrology (Carlton). 2022. PMID: 35678544

10

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.

Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page